Style | Citing Format |
---|---|
MLA | Vajdi M, et al.. "Therapeutic Effect of Fenugreek Supplementation on Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Clinical Trials." Heliyon, vol. 10, no. 17, 2024, pp. -. |
APA | Vajdi M, Noshadi N, Bonyadian A, Golpourhamedani S, Alipour B, Pourteymour Fard Tabrizi F, Abbasalizadfarhangi M, Askari G (2024). Therapeutic Effect of Fenugreek Supplementation on Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Clinical Trials. Heliyon, 10(17), -. |
Chicago | Vajdi M, Noshadi N, Bonyadian A, Golpourhamedani S, Alipour B, Pourteymour Fard Tabrizi F, Abbasalizadfarhangi M, Askari G. "Therapeutic Effect of Fenugreek Supplementation on Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Clinical Trials." Heliyon 10, no. 17 (2024): -. |
Harvard | Vajdi M et al. (2024) 'Therapeutic Effect of Fenugreek Supplementation on Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Clinical Trials', Heliyon, 10(17), pp. -. |
Vancouver | Vajdi M, Noshadi N, Bonyadian A, Golpourhamedani S, Alipour B, Pourteymour Fard Tabrizi F, et al.. Therapeutic Effect of Fenugreek Supplementation on Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Clinical Trials. Heliyon. 2024;10(17):-. |
BibTex | @article{ author = {Vajdi M and Noshadi N and Bonyadian A and Golpourhamedani S and Alipour B and Pourteymour Fard Tabrizi F and Abbasalizadfarhangi M and Askari G}, title = {Therapeutic Effect of Fenugreek Supplementation on Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Clinical Trials}, journal = {Heliyon}, volume = {10}, number = {17}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Vajdi M AU - Noshadi N AU - Bonyadian A AU - Golpourhamedani S AU - Alipour B AU - Pourteymour Fard Tabrizi F AU - Abbasalizadfarhangi M AU - Askari G TI - Therapeutic Effect of Fenugreek Supplementation on Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Clinical Trials JO - Heliyon VL - 10 IS - 17 SP - EP - PY - 2024 ER - |